Physician profile
Steven E Hearne
NPI 1184616088
$100,062.82
in general payments reported to CMS, 2019-2025
44 companies · $12K in 2025
The $12K reported for 2025 was more than what 90% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $31K · 2020: $14K · 2021: $18K · 2022: $8,438 · 2023: $8,426 · 2024: $7,789 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $22K · Food and Beverage: $6,646 · Travel and Lodging: $195 · Education: $43.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $21,701.50 |
| Food and Beverage | $6,646.19 |
| Travel and Lodging | $194.88 |
| Education | $43.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $60,032.92 | 2019-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $15,319.79 | 2019-2025 | |
| Esperion Therapeutics, INC. | $10,653.56 | 2020-2023 | Nexletol |
| Boehringer Ingelheim Pharmaceuticals, INC. | $2,697.20 | 2019-2025 | Jardiance |
| Medtronic Vascular, INC. | $2,110.87 | 2019-2020 | |
| Boston Scientific Corporation | $1,632.61 | 2019-2025 | Watchman Flx, Watchman, Watchman Access System |
| Medtronic, INC. | $1,276.42 | 2021-2025 | Corevalve Evolut R, Onyx Frontier, Aurora Ev-Icd Mri Surescan |
| Abbott Laboratories | $1,195.19 | 2019-2025 | Mitraclip, Thoratec Heartmate 3 Lvas Implant Kit, Triclip |
| Astrazeneca Pharmaceuticals Lp | $818.36 | 2019-2025 | Brilinta, Farxiga, Enhertu |
| Lilly USA, LLC | $675.00 | 2020 | |
| Janssen Pharmaceuticals, INC | $538.26 | 2019-2024 | Xarelto |
| Edwards Lifesciences Corporation | $424.14 | 2019-2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| E.R. Squibb & Sons, L.L.C. | $323.69 | 2019-2025 | Eliquis, Camzyos |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $321.44 | 2019-2025 | Lifevest |
| Pfizer INC. | $313.60 | 2019-2025 |
Show all 38 companies
6 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Hearne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.